GIACOMELLI, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 12.076
NA - Nord America 10.858
EU - Europa 8.161
SA - Sud America 1.257
AF - Africa 559
OC - Oceania 132
Continente sconosciuto - Info sul continente non disponibili 10
Totale 33.053
Nazione #
US - Stati Uniti d'America 10.352
CN - Cina 3.642
SG - Singapore 3.429
IT - Italia 2.409
VN - Vietnam 1.191
HK - Hong Kong 1.037
GB - Regno Unito 1.020
BR - Brasile 951
RU - Federazione Russa 815
DE - Germania 812
IN - India 595
BD - Bangladesh 575
FR - Francia 537
NL - Olanda 481
SE - Svezia 462
ES - Italia 376
ID - Indonesia 376
FI - Finlandia 364
CA - Canada 286
IE - Irlanda 242
JP - Giappone 215
KR - Corea 199
TR - Turchia 163
CI - Costa d'Avorio 156
MX - Messico 136
AU - Australia 125
PL - Polonia 98
AR - Argentina 85
ZA - Sudafrica 82
AT - Austria 79
DK - Danimarca 79
PK - Pakistan 74
PH - Filippine 69
BE - Belgio 63
CO - Colombia 63
IR - Iran 62
CH - Svizzera 57
TH - Thailandia 56
IQ - Iraq 55
TW - Taiwan 50
MY - Malesia 49
SA - Arabia Saudita 43
EC - Ecuador 40
KE - Kenya 40
UA - Ucraina 40
GH - Ghana 39
EG - Egitto 37
PE - Perù 37
PT - Portogallo 33
RO - Romania 32
NG - Nigeria 29
VE - Venezuela 26
CL - Cile 25
IL - Israele 24
MA - Marocco 21
ET - Etiopia 20
GR - Grecia 20
UZ - Uzbekistan 20
AE - Emirati Arabi Uniti 17
NP - Nepal 17
TN - Tunisia 16
CZ - Repubblica Ceca 15
HU - Ungheria 15
JO - Giordania 14
KZ - Kazakistan 14
PY - Paraguay 14
BW - Botswana 13
LT - Lituania 13
SC - Seychelles 13
CM - Camerun 12
BG - Bulgaria 11
GT - Guatemala 11
NO - Norvegia 11
UG - Uganda 11
AZ - Azerbaigian 10
LB - Libano 10
TZ - Tanzania 10
BO - Bolivia 9
LU - Lussemburgo 9
MZ - Mozambico 9
DZ - Algeria 8
JM - Giamaica 8
LK - Sri Lanka 8
LV - Lettonia 8
NI - Nicaragua 8
OM - Oman 8
SI - Slovenia 8
TT - Trinidad e Tobago 8
AM - Armenia 7
HN - Honduras 7
KH - Cambogia 7
MK - Macedonia 7
NZ - Nuova Zelanda 7
QA - Qatar 7
SL - Sierra Leone 7
SN - Senegal 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AL - Albania 6
BY - Bielorussia 6
MT - Malta 6
Totale 32.911
Città #
Singapore 1.930
Ashburn 1.320
Dallas 1.078
Hong Kong 822
San Jose 789
Milan 689
Chandler 661
Southend 587
Beijing 534
Council Bluffs 490
Hefei 471
Los Angeles 389
Ho Chi Minh City 353
Fairfield 301
New York 290
Hanoi 284
Frankfurt am Main 280
Santa Clara 258
Helsinki 241
Dublin 238
Houston 231
Bengaluru 226
Valencia 222
Princeton 206
Lauterbourg 203
Boardman 192
Rome 191
Jakarta 189
Ann Arbor 187
Buffalo 178
Guangzhou 171
Abidjan 156
Moscow 146
Wilmington 143
The Dalles 141
Toronto 141
Redwood City 140
Tokyo 127
Seoul 125
Shanghai 117
Munich 111
Seattle 105
Des Moines 101
Woodbridge 100
São Paulo 99
Chicago 97
Istanbul 93
Cambridge 89
Nuremberg 85
Phoenix 82
Cangzhou 73
London 69
Central District 63
Da Nang 63
Atlanta 59
Warsaw 58
Columbus 57
Dearborn 56
Washington 55
Lappeenranta 51
Orem 51
Nanjing 48
Madrid 46
Turku 45
Chennai 43
Haiphong 43
Bologna 42
Shenzhen 42
Amsterdam 41
Mumbai 41
Tianjin 41
Naples 40
Berlin 39
Bodio Lomnago 38
Brussels 38
Denver 38
Boston 37
Brooklyn 36
Rio de Janeiro 36
Dong Ket 35
Salt Lake City 35
San Diego 35
Johannesburg 34
Paris 34
Vienna 34
Turin 33
Montreal 32
Sydney 31
Accra 30
Bangkok 29
Kuala Lumpur 29
Manchester 28
San Francisco 27
Taipei 27
Lima 26
Belo Horizonte 25
Wuhan 25
Changsha 24
Jena 24
Mexico City 24
Totale 18.409
Nome #
Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population : results from the large Italian web-based EPICOVID19 cross-sectional survey. (Preprint) 556
Non-human primate and human malaria: past, present and future 538
Five years with dolutegravir plus lamivudine as a switch strategy : much more than a positive finding 440
Imported dengue fever: a 16-years retrospective analysis in Milan (Italy) and a brief review of the European literature 415
Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19 : An International, Multicenter Retrospective Meta-analysis 407
A case of crusted scabies with a delayed diagnosis and inadequate therapy 404
Rapid COVID-19 Screening Based on Self-Reported Symptoms:Psychometric Assessment and Validation of the EPICOVID19Short Diagnostic Scale 375
Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational data 351
Does syphilis increase the risk of HIV-RNA elevation >200 copies/mL in HIV positive patients under effective antiretroviral treatment? Data from the ICONA cohort 350
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference 345
Clinical features and outcomes of HIV patients with coronavirus disease 2019 344
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study 333
Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d'Adda, Italy 328
Prevalence and factors associated with HIV-1 multidrug resistance over the past two decades in the Italian Arca database 313
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status 304
Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022 298
Durability of INI-containing regimens after switching from PI-containing regimens : a single-centre cohort of drug-experienced HIV-infected subjects 278
Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF 260
Clinical pharmacology in HIV cure research : what impact have we seen? 259
Differences in the prevalence of SARS-COV-2 infection and access to care between italians and non-italians in a social-housing neighbourhood of Milan, Italy 255
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study 253
Prevalence of extracardiac vascular complications in Abiotrophia spp. and Granulicatella spp. infective endocarditis: Two case reports and a systematic review 249
Iatrogenic Cushing syndrome due to drug interaction between inhaled fluticasone and cobicistat 249
Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study 245
Clinical and genetic determinants of nevirapine plasma trough concentration 240
Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience 238
Delayed diagnosis among patients with cutaneous and mucocutaneous leishmaniasis 234
Self-reported Olfactory and Taste Disorders in Patients with Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study 231
Retinal findings in patients with COVID-19: Results from the SERPICO-19 study 230
Redefining the Prognostic Value of High-Sensitivity Troponin in COVID-19 Patients: The Importance of Concomitant Coronary Artery Disease 228
Dengue fever complicated by liver dysfunction due to possible co-infection with hepatitis E in a returning traveller from Cuba 227
Mortality among Italians and immigrants with COVID-19 hospitalised in Milan, Italy: data from the Luigi Sacco Hospital registry 227
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients 220
An update on integrase inhibitors : new opportunities for a personalized therapy? The NEXTaim Project 219
Imported Dengue Fever in Milan, Italy: A seven-year retrospective study 217
Cohort profile : The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 216
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: a retrospective cohort study 215
Circulating endothelial progenitors are increased in Covid‐19 patients and correlate with SARS‐CoV‐2 RNA in severe cases 214
Seroprevalence of SARS-CoV-2 IgG significantly varies with age: results from a mass population screening (SARS-2-SCREEN-CdA) 213
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 207
Liver tests abnormalities with licensed antiviral drugs for COVID-19: a narrative review 207
Association between smoking and sars-cov-2 infection: Cross-sectional study of the epicovid19 internet-based survey 207
Missed opportunities of flu vaccination in Italian target categories: Insights from the online epicovid 19 survey 205
Correlation between continuous Positive end-expiratory pressure (PEEP) values and occurrence of Pneumothorax and Pneumomediastinum in SARS-CoV2 patients during non-invasive ventilation with Helmet 205
Retinal vessels modifications in acute and post-COVID-19 204
Drug-drug interactions between tirzepatide and antiretrovirals: time to reassess and reassure? 203
Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients 201
Mortality rates among COVID-19 patients hospitalised during the first three waves of the epidemic in Milan, Italy: A prospective observational study 200
Anal HPV prevalence in individuals with and without other concomitant sexually transmitted infections 198
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024 196
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 196
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 195
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy 194
Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis 193
The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation 190
The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection : Data from the EPICOVID19 Web-Based Survey 189
The Impact of the SARS-CoV-2 Outbreak on the Psychological Flexibility and Behaviour of Cancelling Medical Appointments of Italian Patients with Pre-Existing Medical Condition : The “ImpACT-COVID-19 for Patients” Multi-Centre Observational Study 187
Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine 187
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis – results from the ICONA cohort in Italy, 2009-2022 185
Multidrug-resistant HIV viral rebound during early syphilis: a case report 183
Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study 183
Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy 181
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy 180
Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data 178
Viral bloodstream detection in mpox patients: An observational multicentric study 176
Overlooked cases of HIV infection: An Italian tale of missed diagnostic opportunities 175
Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate? 174
Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens 174
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 174
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 172
Hospitalisation for monkeypox in Milan, Italy 171
Delayed psychotropic toxicity after switching from nevirapine to bictegravir: the role of enzyme de-induction in people with HIV and polypharmacy 171
Successful treatment of sexually acquired acute HCV reinfection with ledipasvir/sofosbuvir in a HIV-infected patient 171
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 171
Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older 171
Endemic mycoses: geographical distribution is still a work in progress 171
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced dimalsease: a trial emulation 170
Influenza Vaccination Uptake in the General Italian Population during the 2020–2021 Flu Season: Data from the EPICOVID-19 Online Web-Based Survey 168
Age-Related Changes in Clinical Presentation of Covid19: the EPICOVID19 Web-Based Survey 168
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy 167
Evaluation of analytical performance of the STANDARDTM M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of Monkeypox virus 167
Accessibility to SARS-CoV-2 swab test during the Covid-19 pandemic : Did age make the difference? 164
Screening for Chagas disease in Latin-American pregnant women and their newborns: A prospective observational, multicenter study in Milan, Italy 163
Detecting HCV infection by means of mass population SARS-CoV-2 screening: a pilot experience in Northern Italy 163
Bloodstream Infections in Intensive Care Unit during Four Consecutive SARS-CoV-2 Pandemic Waves 162
Factors involved in continuance of atazanavir-based regimens : Results from a cohort of HIV1-positive patients 159
Cryptococcal Disease Presenting With Cellulitis in Kidney Transplant Recipients 159
Histoplasmosis diagnosed in Europe and Israel: A case report and systematic review of the literature from 2005 to 2020 159
Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients : Potential implications for clinical practice 155
Impact of gender on patients hospitalized for SARS-COV-2 infection: A prospective observational study 155
Preventing HIV mother-to-child transmission in a vertically infected pregnant woman with multiclass drug resistance, role of bis-in-die dolutegravir and neonatal AZT prophylaxis: A case report 152
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study 152
The value of lamp to rule out imported malaria diagnosis: a retrospective observational study in Milan, Italy 151
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025 150
Chagas disease prevalence among migrants from El Salvador in Milan: a cross- sectional study of an often-overlooked population 148
Reply to Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience from the Latindili Network" by Bessone Fernando et al 148
Breakthrough Acute HIV Infections among Pre-Exposure Prophylaxis Users with High Adherence: A Narrative Review 147
Bacterial coinfections in COVID-19 patients without a positive microbiologic result : a word of caution 145
Has COVID-19 changed the approach to HIV diagnosis? A multicentric Italian experience 145
HIV and COVID-19 pandemic collision: turning challenges into opportunity 144
Totale 22.204
Categoria #
all - tutte 102.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021393 0 0 0 0 0 0 0 0 0 0 180 213
2021/20222.476 144 182 163 166 212 229 219 172 301 174 126 388
2022/20232.755 275 262 230 278 249 473 116 157 310 56 250 99
2023/20242.823 155 173 153 209 555 287 186 125 128 167 292 393
2024/20256.548 256 629 131 545 469 311 292 549 369 851 729 1.417
2025/202616.153 1.527 1.714 2.121 1.502 1.226 897 2.103 746 1.502 1.236 1.579 0
Totale 34.219